Languages
简体中文
繁體中文
English
日本語
한국어
Bahasa Indonesia
Tiếng Việt
Sign In
Send a Release
Products
News
Resources
Contact
Search
Search
Products
News
Resources
Contact
Overview
Content Creation
Distribution
Monitoring & Insights
Influencer Database
Falcon
All Products
Send a Release
News
Products
Resources
Contact
Overview
Latest
Regional
Mainland China
Japan
Korea
Indonesia
Malaysia
Singapore
Thailand
Vietnam
Australia
Industry
Auto & Transportation
Business Technology
Consumer Products & Retail
Consumer Technology
Energy
Entertainment & Media
Environment
Financial Services
General Business
Health
Heavy Industry & Manufacturing
Policy & Public Interest
Sports
Telecommunications
Travel
Food and Beverages
Advertising, Marketing and Media
Exhibition
Real Estate and Furniture
Trending Topics
Personnel Announcements
Earnings
New Technologies & New Products
Investment & Financing
Carbon Neutral
China International Consumer Products Expo
Summer Event
Environmental, Social, Governance (ESG)
Sustainability
Mobile World Congress (MWC)
Belt & Road
Artificial Intelligence
American Society of Clinical Oncology (ASCO)
Holiday Season
Consumer Electronics Show (CES)
Canton Fair
Earth Day
Blockchain
China International Import Expo
International Women's Day
Multimedia
Other Languages
Malaysian
Thai
Public Company News
Send a Release
Resources
Products
News
Contact
Overview
Beyond PR Blog
Media Coffee
Client Stories
White Papers
Events in APAC
Media Room
PR Calendar
Send a Release
Contact
Products
Resources
News
Asia Pacific Offices
Request More Information
Alert / Newsletter Subscription
Our Presence on Social Media Sites
FAQs
Send a Release
Products
News
Resources
Contact
Send a Release
Samsung Biologics Co. Ltd.
Media Room
Latest News
Photo News
Photo News
Time
All
2025
2024
2023
2022
2021
2020
2019
2018
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
2024-10-14 19:00
2498
Report
Samsung Biologics launches development platforms for enhanced therapeutic efficacy
2024-09-25 19:00
1877
Report
Samsung Biologics obtains three global ISO certifications
2022-10-13 19:00
1791
Report
'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report
2022-07-11 19:00
2386
Report
Samsung Biologics holds 11th Annual General Meeting of Shareholders
2022-03-29 09:42
2320
Report
Samsung Biologics receives 2022 CMO Leadership Award in all six categories
2022-02-07 20:00
2436
Report
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea
2021-12-14 13:34
2010
Report
Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy
2021-12-14 08:55
2191
Report
Samsung Biologics adds to global ISO certifications with Quality Management System
2021-12-07 13:04
2190
Report
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
2021-11-24 20:00
2455
Report
Samsung Biologics Reports Third Quarter 2021 Financial Results
2021-10-26 15:23
2012
Report
Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA
2021-09-22 18:00
1887
Report
Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative
2021-09-13 12:41
2234
Report
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy
2021-07-20 20:00
1869
Report
Samsung Biologics Issues Its First Annual Sustainability Report
2021-06-25 09:01
22918
Report
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections
2021-06-23 19:28
1657
Report
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate
2021-06-02 19:00
1951
Report
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services
2021-05-31 19:00
2770
Report
Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management
2021-05-28 20:00
3238
Report
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine
2021-05-23 00:00
9559
Report
Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life."
2021-04-21 19:00
1948
Report
1
2
Share:
Share to wechat: